Mahamaya Lifesciences Ltd

BSE: 544611 · Chemicals & Petrochemicals · 4 announcements

Share price: ₹183.00
Market cap: ₹428.3 Cr
Revenue (annual): ₹329.3 Cr
Net profit (annual): ₹16.72 Cr
P/E (TTM): 25.6×Sector 37.5×
Promoter holding: 56.35%
FII holding: 4.77%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

14 Sep 2026 17:18 IST BSE

Promoter Buying

Mahamaya Lifesciences Promoter Buying

Promoter Prashant Krishnamurthy acquired 7,200 equity shares of Mahamaya Lifesciences Ltd through open market purchases on BSE.

Promoter stake change: +0.02%

Read the filing ↗

7 Sep 2026 21:08 IST BSE

Annual Report

Mahamaya Lifesciences Annual Report

Mahamaya Lifesciences Limited has filed its Annual Report for the financial year 2025-26. The document details the company's financial and operational performance.

Read the filing ↗

7 Sep 2026 20:01 IST BSE

Annual General Meeting

Mahamaya Lifesciences Annual General Meeting

Mahamaya Lifesciences Limited has issued the notice for its Annual General Meeting scheduled on September 29, 2026. The agenda includes financial adoption and various director appointments.

Read the filing ↗